La catena delle opzioni mostra i dati chiave delle opzioni azionarie di Inovio Pharmaceuticals a vari prezzi di esercizio e date di scadenza. I trader utilizzano queste informazioni per analizzare potenziali operazioni e valutare il sentiment del mercato per Inovio Pharmaceuticals..

Inovio Pharmaceuticals (NASDAQ:INO) Azioni, Catena delle Opzioni

INOVIO PHARMACEUTICALS INC

Inovio Pharmaceuticals

Inovio Pharmaceuticals Inc is a United States-based biotechnology company. The company is focused on developing and commercializing DNA medicines to help treat and protect people from HPV-associated diseases, cancer and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.

Long Ideas

News

Pre-Market Outlook

Markets

Trading Ideas

OTLK

RCKT

Strategie per individuare titoli con potenziale di crescita basate su indicatori RSI e tendenze di mercato.

Opportunità di investimento: 3 aziende sottovalutate nel settore sanitario

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul class="wp-block-list">
<li>WestPark Capital analyst Curtis Shauger initiated coverage on C3.ai, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AI#NYSE">AI</a>) with a Buy rating and announced a price target of $40. C3.ai shares closed at $26.37 on Tuesday. <a href="https://www.benzinga.com/quote/AI/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Wolfe Research analyst Alex Zukin initiated coverage on MongoDB, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MDB#NASDAQ">MDB</a>) with an Outperform rating and announced a price target of $280. MongoDB shares closed at $208.90 on Tuesday. <a href="https://www.benzinga.com/quote/MDB/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Piper Sandler initiated coverage on Inovio Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INO#NASDAQ">INO</a>) with an Overweight rating and announced a price target of $5. Inovio Pharmaceuticals shares closed at $1.34 on Tuesday. <a href="https://www.benzinga.com/quote/INO/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Stifel analyst Paul Forward initiated coverage on Freeport-McMoRan Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FCX#NYSE">FCX</a>) with a Buy rating and announced a price target of $56. Freeport-McMoRan shares closed at $46.27 on Tuesday. <a href="https://www.benzinga.com/quote/FCX/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>William Blair analyst Sharon Zackfia initiated coverage on Wingstop Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WING#NASDAQ">WING</a>) with an Outperform rating. Wingstop shares closed at $326.65 on Tuesday. <a href="https://www.benzinga.com/quote/WINNG/analyst-ratings">See how other analysts view this stock.</a></li>
</ul>
Considering buying WING stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><a href="https://www.benzinga.com/quote/WING/analyst-ratings"><img loading="lazy" decoding="async" width="1024" height="582" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/09101153/image-99-1024x582.png" alt="" class="wp-image-978485" style="width:581px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/09101153/image-99-1024x582.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/09101153/image-99-300x171.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/09101153/image-99-768x437.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/09101153/image-99.png 1143w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>
Read This Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/trading-ideas/short-ideas/25/07/46296650/top-2-industrials-stocks-you-may-want-to-dump-this-quarter">Top 2 Industrials Stocks You May Want To Dump This Quarter</a> </li>
</ul>
Photo via Shutterstock

Initiation

Analyst Ratings

WING

This Wingstop Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday

Piper Sandler initiates coverage on Inovio Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INO#NASDAQ">INO</a>) with a Overweight rating and announces Price Target of $5.

Price Target

Piper Sandler Initiates Coverage On Inovio Pharmaceuticals with Overweight Rating, Announces Price Target of $5

<h3>Gainers</h3>
<ul>
<li>Sonnet BioTherapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SONN#NASDAQ">SONN</a>) stock increased by 13.8% to $4.46 during Thursday's after-market session. The company's market cap stands at $13.1 million. </li>
<li>Cognition Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CGTX#NASDAQ">CGTX</a>) shares increased by 11.11% to $0.45. The company's market cap stands at $20.7 million. </li>
<li>NeOnc Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NTHI#NASDAQ">NTHI</a>) shares rose 10.29% to $6.43. The company's market cap stands at $100.6 million. </li>
<li>ProKidney (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PROK#NASDAQ">PROK</a>) stock rose 9.85% to $0.7. The company's market cap stands at $74.9 million. </li>
<li>Beta Bionics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BBNX#NASDAQ">BBNX</a>) stock rose 9.17% to $14.76. The market value of their outstanding shares is at $613.0 million. </li>
<li>Inovio Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INO#NASDAQ">INO</a>) shares moved upwards by 9.02% to $1.45. The company's market cap stands at $78.4 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Lixte Biotechnology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LIXT#NASDAQ">LIXT</a>) stock declined by 16.6% to $2.36 during Thursday's after-market session. The company's market cap stands at $5.5 million. </li>
<li>Regencell Bioscience (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RGC#NASDAQ">RGC</a>) shares declined by 14.97% to $19.55. The company's market cap stands at $5.1 billion. As per the news, the H1 earnings report came out 3 days ago. </li>
<li>Indaptus Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INDP#NASDAQ">INDP</a>) stock decreased by 9.09% to $10.11. The company's market cap stands at $6.1 million. </li>
<li>Coherus Oncology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CHRS#NASDAQ">CHRS</a>) shares declined by 8.62% to $0.74. The company's market cap stands at $92.1 million. </li>
<li>Windtree Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WINT#NASDAQ">WINT</a>) shares decreased by 6.38% to $0.87. The market value of their outstanding shares is at $2.8 million. </li>
<li>Trinity Biotech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TRIB#NASDAQ">TRIB</a>) shares decreased by 5.87% to $0.71. The market value of their outstanding shares is at $13.0 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Movers

BBNX

CGTX

CHRS

INDP

LIXT

NTHI

PROK

SONN

TRIB

WINT

12 Health Care Stocks Moving In Thursday's After-Market Session

<h3>Gainers</h3>
<ul>
<li>Regencell Bioscience (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RGC#NASDAQ">RGC</a>) stock moved upwards by 120.3% to $22.82 during Thursday's regular session. The market value of their outstanding shares is at $5.1 billion. As per the news, the H1 earnings report came out 3 days ago. </li>
<li>Lixte Biotechnology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LIXT#NASDAQ">LIXT</a>) shares increased by 41.48% to $2.86. The market value of their outstanding shares is at $5.5 million. </li>
<li>Vor Biopharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VOR#NASDAQ">VOR</a>) stock moved upwards by 31.37% to $1.91. The market value of their outstanding shares is at $181.1 million. </li>
<li>Jupiter Neurosciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JUNS#NASDAQ">JUNS</a>) shares rose 31.14% to $1.56. The company's market cap stands at $39.3 million. </li>
<li>Know Labs (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/KNW#AMEX">KNW</a>) stock rose 27.97% to $2.47. The market value of their outstanding shares is at $14.3 million. </li>
<li>Cognition Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CGTX#NASDAQ">CGTX</a>) stock moved upwards by 23.53% to $0.41. The market value of their outstanding shares is at $20.7 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Inovio Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INO#NASDAQ">INO</a>) shares declined by 37.9% to $1.33 during Thursday's regular session. The company's market cap stands at $78.4 million. </li>
<li>Jyong Biotech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MENS#NASDAQ">MENS</a>) shares decreased by 17.68% to $7.92. The company's market cap stands at $731.3 million. </li>
<li>OneMedNet (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ONMD#NASDAQ">ONMD</a>) shares decreased by 11.74% to $0.56. The company's market cap stands at $28.4 million. </li>
<li>GT Biopharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GTBP#NASDAQ">GTBP</a>) stock fell 11.34% to $2.75. The company's market cap stands at $9.7 million. </li>
<li>Venus Concept (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VERO#NASDAQ">VERO</a>) stock fell 10.54% to $2.64. The market value of their outstanding shares is at $5.4 million. </li>
<li>Zynex (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZYXI#NASDAQ">ZYXI</a>) shares declined by 10.41% to $2.41. The company's market cap stands at $81.3 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

GTBP

JUNS

MENS

ONMD

VERO

ZYXI

12 Health Care Stocks Moving In Thursday's Intraday Session

U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining more 1% on Thursday.
The Dow traded up 0.75% to 44,820.06 while the NASDAQ gained 1.04% to 20,605.03. The S&amp;P 500 also rose, gaining, 0.85% to 6,280.22.
Check This Out: <a href="https://www.benzinga.com/trading-ideas/short-ideas/25/07/46243382/top-3-financial-stocks-you-may-want-to-dump-this-quarter">Top 3 Financial Stocks You May Want To Dump This Quarter</a>
Leading and Lagging Sectors Information technology shares jumped by 1.3% on Thursday.
In trading on Thursday, consumer staples stocks slipped by 0.01%.
Top Headline
Nonfarm payrolls increased by 147,000 in June, the strongest reading so far in 2025, up from an upwardly revised 144,000 in May and well above economists' expectations of 110,000.
The unemployment rate dipped to 4.1% from 4.2%, also beating forecasts for a rise to 4.3%. It marks the lowest unemployment rate since January 2025.
Equities Trading UP &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<ul class="wp-block-list">
<li>Tripadvisor, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TRIP#NASDAQ">TRIP</a>) shares shot up 17% to $17.58 after activist investor Starboard Value acquired a 9% stake in the company.</li>
<li>Shares of La Rosa Holdings Corp. &nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LRHC#NASDAQ">LRHC</a>) got a boost, surging 80% to $0.1439 after the company reported preliminary unaudited revenue of $38.4 million for the first half of 2025.</li>
<li>Olo Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OLO#NYSE">OLO</a>) shares were also up, gaining 14% to $10.13 after the company announced that it entered into a definitive agreement to be acquired by Thoma Bravo.</li>
</ul>
Equities Trading DOWN
<ul class="wp-block-list">
<li>Inovio Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INO#NASDAQ">INO</a>) shares dropped 37% to $1.3486 after the company announced a $25 million public offering.</li>
<li>Shares of Netcapital Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NCPL#NASDAQ">NCPL</a>) were down 35% to $5.52 after the company announced up to a $9.9 million registered direct offering priced at-the-market under Nasdaq rules.</li>
<li>Franklin Covey Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FC#NYSE">FC</a>) was down, falling 12% to $21.34 as the company reported downbeat results for the third quarter and lowered its FY2025 sales guidance after the closing bell on Wednesday.</li>
</ul>
Commodities In commodity news, oil traded down 1% to $66.81 while gold traded down 0.7% at $3,337.00.
Silver traded up 0.6% to $36.93 on Thursday, while copper fell 0.8% to $5.1540.
Euro zone
European shares were higher today. The eurozone's STOXX 600 rose 0.30%, while Spain's IBEX 35 Index rose 0.75%. London's FTSE 100 rose 0.36%, Germany's DAX 40 gained 0.46% and France's CAC 40 gained 0.18% during the session.
Asia Pacific Markets
Asian markets closed mixed on Thursday, with Japan's Nikkei gaining 0.06%, Hong Kong's Hang Seng falling 0.63%, China's Shanghai Composite gaining 0.18% and India's BSE Sensex falling 0.20%.
Economics
<ul class="wp-block-list">
<li>Nonfarm payrolls increased by 147,000 in June, the strongest reading so far in 2025, up from an upwardly revised 144,000 in May and well above economists' expectations of 110,000.</li>
<li>The unemployment rate dipped to 4.1% from 4.2%, also beating forecasts for a rise to 4.3%. It marks the lowest unemployment rate since January 2025.</li>
<li>Average hourly earnings rose just 0.2% on the month, down from 0.4% in May and below the 0.3% expected. Year-over-year wage growth eased from 3.8% to 3.7%, undershooting the 3.9% forecast.</li>
<li>The S&amp;P Global composite PMI fell to 52.9 in June compared to 53.0 in May.</li>
<li>The U.S. trade gap increased to $71.5 billion in May versus a revised $60.3 billion gap in the previous month.</li>
<li>U.S. initial jobless claims fell by 4,000 from the previous week to 233,000 in the week ended June 28, compared to market expectations of 240,000.</li>
<li>U.S. natural-gas stocks rose 55 billion cubic feet for the week ending June 27.</li>
<li>New orders for US manufactured goods rose by 8.2% month-over-month to $642 billion in May.</li>
<li>The ISM services PMI climbed to 50.8 in June versus 49.9 in the previous month, above market estimates of 50.5.</li>
<li>The S&amp;P Global composite PMI fell to 52.9 in June from 53.0 in the previous month.</li>
</ul>
Now Read This: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/analyst-stock-ratings/analyst-color/25/07/46243448/cramer-doesnt-recommend-titan-international-joby-aviation-soars-after-milestone-flight">Cramer Doesn&#8217;t Recommend Titan International, Joby Aviation Soars After Milestone Flight</a> </li>
</ul>
Photo via Shutterstock

Equities

Eurozone

Commodities

Intraday Update

LRHC

NCPL

TRIP

Crude Oil Down 1%; Tripadvisor Shares Jump

U.S. stocks traded higher this morning, with the Dow Jones index gaining more than 200 points on Thursday.
Following the market opening Thursday, the Dow traded up 0.54% to 44,725.87 while the NASDAQ gained 0.61% to 20,518.19. The S&amp;P 500 also rose, gaining, 0.51% to 6,259.36.
Check This Out: <a href="https://www.benzinga.com/trading-ideas/short-ideas/25/07/46243382/top-3-financial-stocks-you-may-want-to-dump-this-quarter">Top 3 Financial Stocks You May Want To Dump This Quarter</a>
Leading and Lagging Sectors Utilities shares jumped by 0.9% on Thursday.
In trading on Thursday, consumer staples stocks slipped by 0.01%.
Top Headline
Nonfarm payrolls increased by 147,000 in June, the strongest reading so far in 2025, up from an upwardly revised 144,000 in May and well above economists' expectations of 110,000.
The unemployment rate dipped to 4.1% from 4.2%, also beating forecasts for a rise to 4.3%. It marks the lowest unemployment rate since January 2025.
Equities Trading UP &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<ul class="wp-block-list">
<li>Global Interactive Technologies, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GITS#NASDAQ">GITS</a>) shares shot up 142% to $3.92.</li>
<li>Shares of La Rosa Holdings Corp. &nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LRHC#NASDAQ">LRHC</a>) got a boost, surging 107% to $0.1658 after the company reported preliminary unaudited revenue of $38.4 million for the first half of 2025.</li>
<li>Lixte Biotechnology Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LIXT#NASDAQ">LIXT</a>) shares were also up, gaining 98% to $4.01. Lixte Biotechnology announced the closing of $5.0 million private placement priced at the market.</li>
</ul>
Equities Trading DOWN
<ul class="wp-block-list">
<li>Inovio Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INO#NASDAQ">INO</a>) shares dropped 38% to $1.3350 after the company announced a $25 million public offering.</li>
<li>Shares of Netcapital Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NCPL#NASDAQ">NCPL</a>) were down 31% to $5.82 after the company announced up to a $9.9 million registered direct offering priced at-the-market under Nasdaq rules.</li>
<li>Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SONN#NASDAQ">SONN</a>) was down, falling 24% to $3.1680.</li>
</ul>
Commodities In commodity news, oil traded down 0.5% to $67.10 while gold traded down 0.4% at $3,345.10.
Silver traded up 0.8% to $37.025 on Thursday, while copper fell 0.5% to $5.1695.
Euro zone
European shares were higher today. The eurozone's STOXX 600 rose 0.4%, while Spain's IBEX 35 Index rose 0.5%. London's FTSE 100 rose 0.5%, Germany's DAX 40 gained 0.4% and France's CAC 40 gained 0.3% during the session.
Asia Pacific Markets
Asian markets closed mixed on Thursday, with Japan's Nikkei gaining 0.06%, Hong Kong's Hang Seng falling 0.63%, China's Shanghai Composite gaining 0.18% and India's BSE Sensex falling 0.20%.
Economics
<ul class="wp-block-list">
<li>Nonfarm payrolls increased by 147,000 in June, the strongest reading so far in 2025, up from an upwardly revised 144,000 in May and well above economists' expectations of 110,000.</li>
<li>The unemployment rate dipped to 4.1% from 4.2%, also beating forecasts for a rise to 4.3%. It marks the lowest unemployment rate since January 2025.</li>
<li>Average hourly earnings rose just 0.2% on the month, down from 0.4% in May and below the 0.3% expected. Year-over-year wage growth eased from 3.8% to 3.7%, undershooting the 3.9% forecast.</li>
<li>The S&amp;P Global composite PMI fell to 52.9 in June compared to 53.0 in May.</li>
<li>The U.S. trade gap increased to $71.5 billion in May versus a revised $60.3 billion gap in the previous month.</li>
<li>U.S. initial jobless claims fell by 4,000 from the previous week to 233,000 in the week ended June 28, compared to market expectations of 240,000.</li>
</ul>
Now Read This: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/analyst-stock-ratings/analyst-color/25/07/46243448/cramer-doesnt-recommend-titan-international-joby-aviation-soars-after-milestone-flight">Cramer Doesn&#8217;t Recommend Titan International, Joby Aviation Soars After Milestone Flight</a> </li>
</ul>
Photo via Shutterstock

Earnings

GITS

Dow Jumps Over 200 Points; US Nonfarm Payrolls Beat Estimates

WIIM

Inovio Pharmaceuticals shares are trading lower after the company announced a $25 million public offering.

<h3>Gainers</h3>
<ul>
<li>Windtree Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WINT#NASDAQ">WINT</a>) stock rose 40.2% to $1.08 during Thursday's pre-market session. The company's market cap stands at $2.8 million. </li>
<li>Liminatus Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LIMN#NASDAQ">LIMN</a>) shares increased by 13.28% to $9.98. The market value of their outstanding shares is at $229.1 million. </li>
<li>Baird Medical Investment (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BDMD#NASDAQ">BDMD</a>) stock rose 12.97% to $4.44. The market value of their outstanding shares is at $145.4 million. </li>
<li>Mira Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MIRA#NASDAQ">MIRA</a>) stock moved upwards by 12.9% to $1.4. The company's market cap stands at $20.9 million. </li>
<li>Modular Medical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MODD#NASDAQ">MODD</a>) stock increased by 12.78% to $0.79. The company's market cap stands at $37.9 million. </li>
<li>OSR Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OSRH#NASDAQ">OSRH</a>) stock increased by 10.07% to $1.53. The market value of their outstanding shares is at $26.7 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Inovio Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INO#NASDAQ">INO</a>) shares declined by 26.2% to $1.58 during Thursday's pre-market session. The company's market cap stands at $78.4 million. </li>
<li>Sonnet BioTherapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SONN#NASDAQ">SONN</a>) stock fell 15.43% to $3.51. The company's market cap stands at $13.1 million. </li>
<li>CNS Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CNSP#NASDAQ">CNSP</a>) stock decreased by 10.79% to $0.84. The market value of their outstanding shares is at $5.1 million. </li>
<li>OneMedNet (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ONMD#NASDAQ">ONMD</a>) shares fell 10.08% to $0.57. The market value of their outstanding shares is at $28.4 million. </li>
<li>INVO Fertility (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IVF#NASDAQ">IVF</a>) shares fell 7.38% to $0.81. The market value of their outstanding shares is at $1.8 million. </li>
<li>Applied DNA Sciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APDN#NASDAQ">APDN</a>) stock fell 7.01% to $4.59. The market value of their outstanding shares is at $2.5 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

APDN

BDMD

CNSP

LIMN

MIRA

MODD

OSRH

12 Health Care Stocks Moving In Thursday's Pre-Market Session

Offerings

INOVIO Prices Offering Of 14,285,715 Shares And Accompanying Warrants At Combined Offering Price Of $1.75/Share; Gross Proceeds $25M

Shares of Datadog Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DDOG#NASDAQ">DDOG</a>) rose sharply in pre-market trading followed the company's <a href="https://www.benzinga.com/markets/equities/25/07/46238464/datadog-stock-surges-11-after-hours-after-making-sp-500-debut">announcement of its inclusion in the S&amp;P 500 index.</a>
S&amp;P Dow Jones announced on July 2, 2025, Datadog is set to join the S&amp;P 500.Datadog will officially replace Juniper Networks (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JNPR#NYSE">JNPR</a>), acquired by Hewlett-Packard Enterprise (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HPE#NYSE">HPE</a>), in the index. This change will be effective before the market opens on July 9, 2025.
Datadog shares surged 10.6% to $149.24 in the pre-market trading session.
Here are some other stocks moving in pre-market trading.
<h3 class="wp-block-heading">Gainers</h3>
<ul class="wp-block-list">
<li>Global Interactive Technologies, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GITS#NASDAQ">GITS</a>) surged 217.7% to $5.18 in pre-market trading after gaining over 16% on Wednesday.</li>
<li>FiEE, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MINM#NASDAQ">MINM</a>) gained 38.2% to $3.69 in pre-market trading after the company entered into an asset purchase agreement with Suzhou Yixuntong to acquire intellectual property and fixed assets for $1.4 million.</li>
<li>Theratechnologies Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/THTX#NASDAQ">THTX</a>) climbed 32.2% to $3.12 in pre-market trading after the company agreed to be acquired by CB Biotechnology for $3.01 per share plus contingent value right.</li>
<li>MIRA Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MIRA#NASDAQ">MIRA</a>) rose 30.7% to $1.62 in pre-market trading. After the announcement of Mira-55, a synthetic analog of marijuana, providing pain relief comparable to morphine, the stock value of MIRA Pharmaceutical exploded, signaling an aggressive investor buying.</li>
<li>reAlpha Tech Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AIRE#NASDAQ">AIRE</a>) jumped 26.9% to $0.41 in pre-market trading after the company announced the launch of its AI-powered loan officer assistant.</li>
<li>Aebi Schmidt Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AEBI#NASDAQ">AEBI</a>) gained 26.6% to $14.15 in pre-market trading after dipping over 86% on Wednesday.</li>
<li>Xponential Fitness Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XPOF#NYSE">XPOF</a>) gained 20.6% to $9.00 in pre-market trading after the company disclosed in a Form 8 filing that the SEC concluded its investigation without action.</li>
<li>Bitfarms Ltd (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BITF#NASDAQ">BITF</a>) gained 10% to $1.11 in pre-market trading after jumping around 20% on Wednesday.</li>
</ul>
<h3 class="wp-block-heading">Losers</h3>
<ul class="wp-block-list">
<li>Fly-E Group Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FLYE#NASDAQ">FLYE</a>) shares tumbled 25.8% to $0.58 in pre-market trading. Fly-E Group shares fell around 20% on Wednesday after the company announced a 1-for-5 reverse stock split.</li>
<li>Gibo Holdings Ltd (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GIBO#NASDAQ">GIBO</a>) fell 25% to $0.089 in pre-market trading after gaining around 9% on Wednesday.</li>
<li>Inovio Pharmaceuticals Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INO#NASDAQ">INO</a>) dipped 23.4% to $1.64 in pre-market trading after the company announced a proposed public offering.</li>
<li>Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SONN#NASDAQ">SONN</a>) dipped 15.5% to $3.50 in pre-market trading after gaining 243% on Wednesday.</li>
<li>La Rosa Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LRHC#NASDAQ">LRHC</a>) declined 14% to $0.069 in pre-market trading. La Rosa Holdings shares dipped 37% on Wednesday after the company announced an 80-for-1 reverse stock split effective July 7.</li>
<li>Nuwellis Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NUWE#NASDAQ">NUWE</a>) fell 12.6% to $0.19 in pre-market trading following a 5% decline on Wednesday.</li>
<li>BioNexus Gene Lab Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BGLC#NASDAQ">BGLC</a>) fell 11.4% to $6.04 in pre-market trading after dipping over 38% on Wednesday.</li>
<li>Mogo Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MOGO#NASDAQ">MOGO</a>) declined 11% to $2.29 in pre-market trading. Mogo shares jumped 112% on Wednesday after the company announced a $50 million bitcoin treasury authorization.</li>
<li>Noah Holdings Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOAH#NYSE">NOAH</a>) shares fell 7.3% to $11.69 in pre-market trading.</li>
<li>Borr Drilling Ltd (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BORR#NYSE">BORR</a>) fell 4.7% to $2.01 in pre-market trading after the company announced a $100 million offering of approximately 50 million shares.</li>
</ul>
Now Read This: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/analyst-stock-ratings/analyst-color/25/07/46218519/jim-cramer-gives-utilities-stock-a-week-says-doge-not-done-clobbering-booz-allen">Jim Cramer Gives Utilities Stock &#8216;A Week,&#8217; Says DOGE &#8216;Not Done Clobbering&#8217; Booz Allen</a> </li>
</ul>
Photo via Shutterstock

AEBI

AIRE

BGLC

BITF

BORR

DDOG

FLYE

GIBO

JNPR

MINM

MOGO

NOAH

NUWE

THTX

XPOF

Why Datadog Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket

<h3>Gainers</h3>
<ul>
<li>Mira Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MIRA#NASDAQ">MIRA</a>) shares increased by 58.9% to $1.97 during Wednesday's after-market session. The market value of their outstanding shares is at $20.4 million. </li>
<li>SeaStar Medical Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ICU#NASDAQ">ICU</a>) shares rose 14.6% to $0.64. The market value of their outstanding shares is at $7.8 million. </li>
<li>Inventiva (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IVA#NASDAQ">IVA</a>) shares increased by 7.72% to $3.2. The company's market cap stands at $414.4 million. </li>
<li>I-MAB (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IMAB#NASDAQ">IMAB</a>) shares moved upwards by 7.59% to $2.46. The company's market cap stands at $189.2 million. </li>
<li>FibroGen (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FGEN#NASDAQ">FGEN</a>) shares increased by 7.42% to $5.64. The market value of their outstanding shares is at $21.3 million. </li>
<li>Sera Prognostics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SERA#NASDAQ">SERA</a>) stock moved upwards by 6.77% to $2.6. The company's market cap stands at $97.5 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Inovio Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INO#NASDAQ">INO</a>) shares decreased by 23.4% to $1.64 during Wednesday's after-market session. The company's market cap stands at $74.8 million. </li>
<li>Sonnet BioTherapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SONN#NASDAQ">SONN</a>) stock declined by 15.67% to $3.5. The company's market cap stands at $3.8 million. </li>
<li>Cerus (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CERS#NASDAQ">CERS</a>) shares declined by 12.44% to $1.37. The company's market cap stands at $282.9 million. </li>
<li>Venus Concept (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VERO#NASDAQ">VERO</a>) stock declined by 7.46% to $2.73. The company's market cap stands at $4.8 million. </li>
<li>Catheter Precision (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/VTAK#AMEX">VTAK</a>) shares declined by 7.1% to $0.23. The market value of their outstanding shares is at $2.9 million. </li>
<li>Autonomix Medical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMIX#NASDAQ">AMIX</a>) stock declined by 6.58% to $1.42. The company's market cap stands at $3.9 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AMIX

CERS

FGEN

IMAB

SERA

VTAK

12 Health Care Stocks Moving In Wednesday's After-Market Session

Inovio shares are trading lower after the company announced a proposed public offering.

INOVIO Announces Proposed Public Offering, Size Not Disclosed

Avacta Group plc (AIM: AVCT), a life sciences company developing innovative, targeted oncology drugs,&nbsp;today announces the appointment of David Liebowitz, M.D., Ph.D. as Chief Medical Officer (CMO) and Yulii Bogatyrenko as an advisor in business development. Dr. Liebowitz will lead the Company's clinical strategy and execution as it continues to advance its pipeline of targeted cancer therapies and Mr. Bogatyrenko will add additional strength to the Group's business development strategy.
Dr. Liebowitz is a seasoned hematologist-oncologist and drug development leader with more than 30 years of experience across academia and industry and has contributed to the successful filing of more than 25 Investigational New Drug (IND) applications. He joins Avacta from Inovio Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INO#NASDAQ">INO</a>), where he served as Senior Vice President of early-stage clinical development, overseeing the clinical strategy for DNA-based vaccines and immunotherapies. Prior to that, he held senior roles at Xencor, Vaxart, and Amgen, with a consistent focus on oncology, immunotherapy, and translational science. At Vaxart, Dr. Liebowitz led the acquisition and execution of a significant BARDA contract as principal investigator, culminating in successful completion of the award. Earlier in his career, he held key R&amp;D leadership roles at Amgen, where he directed oncology and vascular biology drug discovery at the company's Washington research site.
 &nbsp;

Avacta Appoints Dr. David Liebowitz as Chief Medical Officer to Lead Cancer Drug Strategy

https://www.who.int/news/item/09-06-2025-fourth-meeting-of-the-international-health-regulations-(2005)-emergency-committee-regarding-the-upsurge-of-mpox-2024-temporary-recommendations

AEMD

GOVX

MRNA

TNXP

VRAX

World Health Organization Says MPOX Remains A Public Health Emergency Of International Concern

RBC Capital analyst Gregory Renza reiterates Inovio Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INO#NASDAQ">INO</a>) with a Sector Perform and maintains $5 price target.

Reiteration

RBC Capital Reiterates Sector Perform on Inovio Pharmaceuticals, Maintains $5 Price Target

Oppenheimer analyst Jay Olson maintains Inovio Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INO#NASDAQ">INO</a>) with a Outperform and lowers the price target from $15 to $13.

Oppenheimer Maintains Outperform on Inovio Pharmaceuticals, Lowers Price Target to $13

Inovio Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INO#NASDAQ">INO</a>) reported quarterly losses of $(0.51) per share. This is a 61.07 percent increase over losses of $(1.31) per share from the same period last year. The company reported $65.34 thousand in sales this quarter.

Inovio Pharmaceuticals Q1 EPS $(0.51) Up From $(1.31) YoY, Sales $65.34K Up from 0 YoY

ABOS

ABSI

ACCS

ACHV

ACXP

ADAP

ALCO

ALLO

ASNS

AUID

AVXL

BDSX

BEAT

BKTI

BWAY

BWEN

CAMT

CAPR

CINT

CLPT

CLRB

CNCK

CYBR

DARE

DLPN

DMAC

ELMD

ETON

EXEL

FENC

FLOC

FTHM

GAIN

GAUZ

GENK

GEVO

GNSS

GOCO

GRAL

GUTS

HSON

HUMA

HUYA

HYFM

HYLN

HYPR

ICMB

IMOS

INLX

IRIX

ITRM

IZEA

KOPN

KRMN

LCTX

LEGN

LOAR

LSTR

LUNR

LXRX

MASS

MBRX

MCHX

MDAI

MGNX

MPTI

NMTC

NPCE

NUTX

NXGL

NYAX

OKLO

ONON

OPXS

PERI

PRTS

PSFE

PXLW

Earnings Scheduled For May 13, 2025

This whale alert can help traders discover the next big trading opportunities.
Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.
Traders often look for circumstances when the market estimation of an option diverges away from its normal worth. Abnormal amounts of trading activity could push option prices to hyperbolic or underperforming levels. 
Below are some instances of options activity happening in the Health Care sector: 
<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th align="right">Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>INO</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>11/21/25</td>
<td>$2.00</td>
<td>$30.8K</td>
<td align="right">332</td>
<td>4.0K</td>
</tr>
<tr>
<td>LLY</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>05/02/25</td>
<td>$820.00</td>
<td>$35.4K</td>
<td align="right">141</td>
<td>1.1K</td>
</tr>
<tr>
<td>RARE</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>08/15/25</td>
<td>$45.00</td>
<td>$44.3K</td>
<td align="right">255</td>
<td>1.0K</td>
</tr>
<tr>
<td>ABBV</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>05/16/25</td>
<td>$182.50</td>
<td>$28.8K</td>
<td align="right">780</td>
<td>752</td>
</tr>
<tr>
<td>LNTH</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>05/16/25</td>
<td>$100.00</td>
<td>$81.1K</td>
<td align="right">468</td>
<td>324</td>
</tr>
<tr>
<td>JNJ</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/15/27</td>
<td>$165.00</td>
<td>$79.9K</td>
<td align="right">302</td>
<td>65</td>
</tr>
<tr>
<td>MRK</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>06/18/26</td>
<td>$85.00</td>
<td>$34.1K</td>
<td align="right">236</td>
<td>59</td>
</tr>
<tr>
<td>PODD</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$260.00</td>
<td>$35.7K</td>
<td align="right">5</td>
<td>10</td>
</tr>
</tbody>
</table>

<h2>Explanation</h2>
These bullet-by-bullet explanations have been constructed using the accompanying table. 
• Regarding INO (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INO#NASDAQ">INO</a>), we observe a call option sweep with bearish sentiment. It expires in 204 day(s) on November 21, 2025. Parties traded 684 contract(s) at a $2.00 strike. This particular call needed to be split into 10 different trades to become filled. The total cost received by the writing party (or parties) was $30.8K, with a price of $45.0 per contract. There were 332 open contracts at this strike prior to today, and today 4000 contract(s) were bought and sold. 
• Regarding LLY (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LLY#NYSE">LLY</a>), we observe a call option sweep with bearish sentiment. It expires in 1 day(s) on May 2, 2025. Parties traded 43 contract(s) at a $820.00 strike. This particular call needed to be split into 12 different trades to become filled. The total cost received by the writing party (or parties) was $35.4K, with a price of $836.0 per contract. There were 141 open contracts at this strike prior to today, and today 1130 contract(s) were bought and sold. 
• For RARE (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RARE#NASDAQ">RARE</a>), we notice a call option sweep that happens to be bullish, expiring in 106 day(s) on August 15, 2025. This event was a transfer of 80 contract(s) at a $45.00 strike. This particular call needed to be split into 24 different trades to become filled. The total cost received by the writing party (or parties) was $44.3K, with a price of $560.0 per contract. There were 255 open contracts at this strike prior to today, and today 1028 contract(s) were bought and sold. 
• For ABBV (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ABBV#NYSE">ABBV</a>), we notice a call option sweep that happens to be bearish, expiring in 15 day(s) on May 16, 2025. This event was a transfer of 22 contract(s) at a $182.50 strike. This particular call needed to be split into 3 different trades to become filled. The total cost received by the writing party (or parties) was $28.8K, with a price of $1310.0 per contract. There were 780 open contracts at this strike prior to today, and today 752 contract(s) were bought and sold. 
• For LNTH (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LNTH#NASDAQ">LNTH</a>), we notice a put option sweep that happens to be bearish, expiring in 15 day(s) on May 16, 2025. This event was a transfer of 163 contract(s) at a $100.00 strike. This particular put needed to be split into 53 different trades to become filled. The total cost received by the writing party (or parties) was $81.1K, with a price of $500.0 per contract. There were 468 open contracts at this strike prior to today, and today 324 contract(s) were bought and sold. 
• For JNJ (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JNJ#NYSE">JNJ</a>), we notice a call option trade that happens to be bearish, expiring in 624 day(s) on January 15, 2027. This event was a transfer of 65 contract(s) at a $165.00 strike. The total cost received by the writing party (or parties) was $79.9K, with a price of $1230.0 per contract. There were 302 open contracts at this strike prior to today, and today 65 contract(s) were bought and sold. 
• For MRK (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MRK#NYSE">MRK</a>), we notice a call option trade that happens to be bearish, expiring in 413 day(s) on June 18, 2026. This event was a transfer of 33 contract(s) at a $85.00 strike. The total cost received by the writing party (or parties) was $34.1K, with a price of $1035.0 per contract. There were 236 open contracts at this strike prior to today, and today 59 contract(s) were bought and sold. 
• For PODD (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PODD#NASDAQ">PODD</a>), we notice a put option sweep that happens to be bullish, expiring in 260 day(s) on January 16, 2026. This event was a transfer of 10 contract(s) at a $260.00 strike. This particular put needed to be split into 4 different trades to become filled. The total cost received by the writing party (or parties) was $35.7K, with a price of $3570.0 per contract. There were 5 open contracts at this strike prior to today, and today 10 contract(s) were bought and sold. 
Options Alert Terminology 
 - Call Contracts: The right to buy shares as indicated in the contract. 
 - Put Contracts: The right to sell shares as indicated in the contract. 
 - Expiration Date: When the contract expires. One must act on the contract by this date if one wants to use it. 
 - Premium/Option Price: The price of the contract. 
For more information, visit our <a href="https://pro.benzinga.com/blog/how-to-understand-option-alerts/">Guide to Understanding Options Alerts</a> or read <a href="https://www.benzinga.com/markets/options">more about unusual options activity</a>. 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Options

ABBV

LNTH

PODD

RARE

8 Health Care Stocks Whale Activity In Today's Session

Press Releases

INOVIO Announces Promising Interim Results from Ongoing Proof-of-Concept Clinical Trial of DNA-Encoded Monoclonal Antibodies (DMAbs) for COVID-19

INOVIO Reports Fourth Quarter and Full Year 2024 Financial Results and Operational Highlights

Comments

Inovio Pharmaceuticals

Inovio Pharmaceuticals (INO) Opzioni

Inovio Pharmaceuticals (NASDAQ:INO) Azioni, Catena delle Opzioni

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO